DE59607840D1 - Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen - Google Patents

Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen

Info

Publication number
DE59607840D1
DE59607840D1 DE59607840T DE59607840T DE59607840D1 DE 59607840 D1 DE59607840 D1 DE 59607840D1 DE 59607840 T DE59607840 T DE 59607840T DE 59607840 T DE59607840 T DE 59607840T DE 59607840 D1 DE59607840 D1 DE 59607840D1
Authority
DE
Germany
Prior art keywords
glycoproteins
glycosylation
bioavailability
characterizing
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59607840T
Other languages
English (en)
Inventor
Peter Hermentin
Reinhild Witzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PETER HERMENTIN, DE
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Priority to DE59607840T priority Critical patent/DE59607840D1/de
Application granted granted Critical
Publication of DE59607840D1 publication Critical patent/DE59607840D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE59607840T 1995-07-26 1996-05-30 Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen Expired - Lifetime DE59607840D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE59607840T DE59607840D1 (de) 1995-07-26 1996-05-30 Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19527054A DE19527054A1 (de) 1995-07-26 1995-07-26 Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
DE59607840T DE59607840D1 (de) 1995-07-26 1996-05-30 Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen
PCT/EP1996/002319 WO1997005490A1 (de) 1995-07-26 1996-05-30 Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen

Publications (1)

Publication Number Publication Date
DE59607840D1 true DE59607840D1 (de) 2001-11-08

Family

ID=7767674

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19527054A Withdrawn DE19527054A1 (de) 1995-07-26 1995-07-26 Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
DE59607840T Expired - Lifetime DE59607840D1 (de) 1995-07-26 1996-05-30 Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19527054A Withdrawn DE19527054A1 (de) 1995-07-26 1995-07-26 Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen

Country Status (13)

Country Link
US (1) US6096555A (de)
EP (1) EP0843821B1 (de)
JP (1) JP3631495B2 (de)
KR (1) KR19990035943A (de)
AT (1) ATE206524T1 (de)
AU (1) AU6003296A (de)
CA (1) CA2227743C (de)
DE (2) DE19527054A1 (de)
DK (1) DK0843821T3 (de)
ES (1) ES2162652T3 (de)
NO (1) NO980276L (de)
PT (1) PT843821E (de)
WO (1) WO1997005490A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020144310A1 (en) * 2000-01-28 2002-10-03 Lightfoot David A. Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
US20030096281A1 (en) * 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
KR100982922B1 (ko) * 2002-01-17 2010-09-20 론자 바이올로직스 피엘씨 단백질을 생산할 수 있으며 무글루타민 배지에서 성장할 수있는 글루타민-요구성 인간세포
EP1587408A4 (de) * 2002-12-20 2007-09-05 Momenta Pharmaceuticals Inc Glycan-marker zur diagnose und überwachung von erkrankungen
JP4077339B2 (ja) * 2003-03-06 2008-04-16 独立行政法人科学技術振興機構 高等植物の糖リン酸の網羅的分析法
DE102005050580A1 (de) * 2005-10-21 2007-04-26 Siegfried Biologics Gmbh Verfahren zur Charakterisierung der Qualität von Sialoglycoproteinen über eine Isoformenzahl I und dessen Verwendung
EP2358731B1 (de) * 2008-12-19 2016-03-09 Momenta Pharmaceuticals, Inc. Verfahren bezüglich modifizierter glykane
AU2011237442A1 (en) 2010-04-07 2012-10-18 Momenta Pharmaceuticals, Inc. High mannose glycans
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
KR101380740B1 (ko) * 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US9150841B2 (en) 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
WO2014186310A1 (en) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins

Also Published As

Publication number Publication date
DK0843821T3 (da) 2002-01-28
ES2162652T3 (es) 2002-01-01
NO980276D0 (no) 1998-01-21
PT843821E (pt) 2002-03-28
KR19990035943A (ko) 1999-05-25
JP2000503109A (ja) 2000-03-14
CA2227743A1 (en) 1997-02-13
AU6003296A (en) 1997-02-26
CA2227743C (en) 2008-01-29
EP0843821A1 (de) 1998-05-27
US6096555A (en) 2000-08-01
EP0843821B1 (de) 2001-10-04
WO1997005490A1 (de) 1997-02-13
MX9800690A (es) 1998-09-30
NO980276L (no) 1998-01-21
ATE206524T1 (de) 2001-10-15
JP3631495B2 (ja) 2005-03-23
DE19527054A1 (de) 1997-01-30

Similar Documents

Publication Publication Date Title
ATE206524T1 (de) Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in- vitro bestimmung der bioverfügbarkeit von glycoproteinen
DE59610276D1 (de) Aerogel- und klebstoffhaltiges verbundmaterial, verfahren zu seiner herstellung sowie seine verwendung
AU4837999A (en) System and method of assessing the quality of an identification transaction using an identification quality score
TR199600357A2 (tr) Rekombinant simanlik (Ob) proteinleri.
DE69614309T2 (de) System und Verfahren zur Ermittlung von verallgemeinerten Assoziationsregeln in Datenbanken
AU1172099A (en) Biometric system and techniques suitable therefor
DE69627839D1 (de) Caseinphosphopeptide und dasselbe enthaltende casein, sowie verfahren in dessem herstellung
EE03424B1 (et) Allergiavastase valguhüdrolüsaadipreparaadi valmistamise meetod
DE69636854D1 (de) Zugriffs- und lieferungssystem für on-line/informationsdienste
EP1264890A3 (de) Plasmodium vivax Blutphaseantigene, dagegen gerichtete Antikörper und diagnostische Verfahren
ITBO950015A0 (it) Endoprotesi coronarica e metodo per la sua realizzazione
DE69725611D1 (de) Nicht-Nukleotid verknüpfende Reagentien
DE59601822D1 (de) Verfahren zur herstellung von weizenproteinhydrolysaten
AU7235298A (en) Fingerprint developing agent and method for developing fingerprints
IL122606A (en) (S)-hydroxa-nitrile-lyase
DE69507594T2 (de) Bildverarbeitungsverfahren zur Ermittlung von Gesichtsmerkmalen
FI970436A0 (fi) Menetelmä tunnistamattoman tilaajan hätäpuhelun muMenetelmä tunnistamattoman tilaajan hätäpuhelun muItselukkiutuva merkintä odostamiseksi langattomassa tilaajaverkossa odostamiseksi langattomassa tilaajaverkossa
AU6220096A (en) Method for the simultaneous detection of different antibodies and/or antigens
DE69708335T2 (de) Bildverarbeitungssystem und -verfahren unter verwendung von personifizierungstechniken
AU6591196A (en) Integrated circuit chip card and the method and system for the manufacture of same
HU9602914D0 (en) Method of inactivating viruses in proteins
WO1999021994A3 (en) Human vesicle membrane protein-like proteins
AU5141098A (en) Method and system for identification of registered articles
BG102479A (en) Mew peptides, method for their preparation and application
PL306885A1 (en) Method of preparing chrome leather discards for utilisation especially for obtaining gelatine and hide glue from them

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

R081 Change of applicant/patentee

Ref document number: 843821

Country of ref document: EP

Owner name: PETER HERMENTIN, DE

Free format text: FORMER OWNER: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT, DE

Effective date: 20120918